Business
Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2025 Financial Results
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its fourth quarter and year-end 2025 financial results conference call and webcast for 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on February 11, 2026.
About this update from Neurocrine Biosciences, Inc.
[{"type":"text","content":"Conference Call and Webcast Scheduled for Wednesday, February 11","length":64,"tagName":"p","attribs":{}},{"type":"text","content":"SAN DIEGO, Jan. 21, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its fourth quarter and year-end 2025 financial results conference call and webcast for 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on February 11, 2026.","length":279,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Neurocrine Biosciences, Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Neurocrine Biosciences, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":74,"url":"https://media.zenfs.com/en/prnewswire.com/9adfb0c84e7d306b48de2742f62d85d4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/T_HafQLyqDkZ5Jiojrk_IQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEzMDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/9adfb0c84e7d306b48de2742f62d85d4","width":400,"height":74}},"href":"https://mma.prnewswire.com/media/678850/Neurocrine_Biosciences_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The schedule for the press release and conference call / webcast is as follows:","length":79,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Q4 and Year-End 2025 Press Release: February 11, 2026 at 1:00 p.m. PT / 4:00 p.m. ET","length":84,"tagName":"p"}]},{"val":[{"type":"text","content":"Q4 and Year-End 2025 Conference Call: February 11, 2026 at 1:30 p.m. PT / 4:30 p.m. ET","length":86,"tagName":"p"}]},{"val":[{"type":"text","content":"Domestic Dial-In Number: 800-579-2543","length":37,"tagName":"p"}]},{"val":[{"type":"text","content":"International Dial-In Number: 785-424-1789","length":42,"tagName":"p"}]},{"val":[{"type":"text","content":"Conference ID: NBIX","length":19,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":268,"olType":false},{"type":"text","content":"The webcast can also be accessed on Neurocrine Biosciences' website under Investors at www.neurocrine.com. A replay of the webcast will be available on the website approximately one hour after the conclusion of the event and will be archived for approximately one month.","length":274,"tagName":"p"},{"type":"text","content":"About Neurocrine BiosciencesNeurocrine Biosciences is a leading biopharmaceutica...